ARAN BIOMEDICAL
LIVE

Serial Number

87856772

Owner

Aran Biomedical Teoranta

Attorney

Michael Horvath

Filing Date

Mar 30, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ARAN BIOMEDICAL Trademark

Serial Number: 87856772 • Registration: 5929796

ARAN BIOMEDICAL is a trademark filed by Aran Biomedical Teoranta on March 30, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing). The application is currently registered and active.

Owner Contact Info

Aran Biomedical Teoranta (4 trademarks)

Galway H91C2NF , IE

Entity Type: 03

Trademark Details

Filing Date

March 30, 2018

Registration Date

December 10, 2019

Published for Opposition

September 24, 2019

Goods & Services

Manufacturing services, namely, custom manufacturing of parts and components for use in medical devices to the order and/or specification of others; Manufacturing and fabrication services of medical components and materials for others, in the nature of medical devices; Custom manufacturing of medical devices, medical instruments, implantable medical devices and their structural components; Processing of medical components, namely, manufacturing of wire formed stents, [ laser cut stents, ] braided stents, covered and uncovered stents for peripheral, coronary, neurovascular, venous, endovascular, gastroenterology, arteriovenous shunts, renal stents, and urinary stents, [ surgical grafts ] transcatheter grafts [ bypass grafts] , clot retrieval devices, aneurysm filling devices, peripheral occluders, venous occluders, structural heart occluders, surgical and transcatheter valve replacement devices, mitral valve replacement devices, aortic valve replacement devices, tricuspid and pulmonary valve replacement devices, surgical and transcatheter valve repair devices, mitral valve repair devices, aortic valve repair devices, tricuspid and pulmonary valve repair devices, embolic protection devices, flowdiversion devices, heart failure devices and implants, [ robotic surgical instrument components and manual surgical instrument components, ] interventional delivery and access systems, interventional balloon, catheters, retrieval devices, [ implantable plates, bones, pins, nails and screws, ] interventional closure devices., aspiration devices, drainage devices, [ filtration devices, venous valve repair devices, valved stents for venous, pulmonary, arterial, urinary, renal, neural and gastrointestinal applications, heart rhythm devices, electrophysiology devices, neuromodulation devices, ablation devices, ] implant containment devices, [ sheaths and sheath leads, surgical pledgets, ] sutures, suture passing device, [ suture anchors, ] tissue reinforcement scaffolds, [ biologic containment mesh, ] spinal stabilization bands, mesh and suture for aesthetic applications, [ scaffolds for cartilage, bone and ligament repair, ] hernia repair meshes, urinary slings for bladder control, meshes for pelvic prolapse [ , penile implants, cerclage cables, and wound closure devices and patches ]

[ Grafts, namely, skin grafts, arterial grafts; Implants comprising living tissue for treating congestive heart failure; Implantable scaffolds comprising living tissue for reinforcing tissue contour; Surgical mesh comprised primarily of living tissue for aesthetic applications; Surgical dressings, namely, pledgets; Wound closure devices and patches in the nature of adhesive bandages; all of the foregoing for use in the fields of cardiac rhythm management, gastroenterology, interventional bronchoscopy, interventional cardiology, interventional radiology, neurovascular intervention, oncology, pain management, urology, and women' s health ]

Wire formed stents, laser cut stents, braided stents, covered and uncovered stents for peripheral, [ coronary, ] neurovascular, [ venous, ] endovascular, gastroenterology, [ arteriovenous shunts, ] renal stents, [ and urinary stents; Surgical synthetic stent grafts, transcatheter, synthetic bone grafts, bypass artificial vascular grafts ] ; Clot retrieval devices; Aneurysm filling devices; Peripheral vascular occluders, [ venous occluders, ] structural heart occluders; Surgical and transcatheter valve replacement devices, mitral valve replacement devices, aortic valve replacement devices, tricuspid and pulmonary valve replacement devices, surgical and transcatheter valve repair devices, mitral valve repair devices, aortic valve repair devices, tricuspid and pulmonary valve repair devices; Embolic protection devices for treating anomalies vasculature of the body; Flow-diversion devices for treating anomalies vasculature of the body; Devices and implants comprising artificial material for treating congestive heart failure; Robotic surgical instrument components and manual surgical instrument components; [ interventional balloon catheters, catheters, foreign body and polyp retrieval devices; Implantable plates, bones, pins, nails and screws, all consisting of artificial materials, Interventional vascular closure devices comprising artificial materials; Aspiration devices being electric and manual sputum aspirators, nasal aspirators; Wound drainage devices; Venous valve repair devices; Valved stents for venous, pulmonary, arterial, urinary, renal, neural and gastrointestinal applications; Heart rhythm devices in the nature of heart rate monitors; Electrophysiology devices in the nature of pacemakers and implantable cardioverter defibrillators; Neuromodulation devices in the nature of non-invasive electronic neuromodulator device for medical use by healthy and impaired persons to enhance performance; Ablation devices in the nature of cryosurgical apparatus for use in performing ablative surgery, catheters for use in cardiac ablation, radio-surgical apparatus for use in performing radiofrequency ablation; Artificial implant containment devices; Surgical instrument sheaths and sheath leads; Surgical sutures, suture passing device, suture anchors; ] Implantable scaffolds comprising artificial materials for reinforcing tissue contour; Biologic containment mesh comprised primarily of artificial materials; Spinal stabilization bands; Surgical mesh comprised primarily of artificial materials and suture for aesthetic applications; Implantable scaffolds comprising artificial materials for cartilage, bone and ligament repair; Hernia repair surgical meshes comprised primarily of artificial materials; Urinary slings for bladder control; Surgical meshes comprised primarily of artificial materials for pelvic prolapse; [ Penile implants consisting of artificial materials; Cerclage cables and wound closure devices in the nature of sutures; ] Medical textiles composed of artificial materials, namely, polymeric and metallic textiles and resorbable synthetic biomaterial structures for use in orthopedic, cardiovascular, general surgical and regenerative medicine applications; Medical textiles composed of artificial materials for use in surgical applications, namely, woven, non-woven, knitted and braided polymeric, resorbable and metallic textile structures; [ Implantable medical textiles composed of artificial materials for use in orthopedic, cardiovascular, and general surgery; Implantable medical textiles composed of synthetic biomaterials for regenerative medicine and for use in orthopedic, cardiovascular, neurovascular, and general surgery; Implantable synthetic bioresorbable materials for medical use, namely, bioresorbable resinous oligomers and polymers for therapeutic and reconstructive use and for use in regenerative medicine, tissue engineering and wound care; ] All of the foregoing being medical, dental and surgical apparatus, implants, devices and instruments for use in the fields of cardiac rhythm management, gastroenterology, interventional bronchoscopy, interventional cardiology, interventional radiology, neurovascular intervention, oncology, pain management, urology, and women' s health

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 18, 2025 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 18, 2025 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 7, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Apr 4, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 10, 2024 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 22, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 22, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 22, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 22, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 22, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 22, 2022 COAR
REGISTERED-PRINCIPAL REGISTER
Dec 10, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2019 NPUB
PUBLISHED FOR OPPOSITION
Sep 24, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 4, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 20, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 17, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 17, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 17, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 17, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 12, 2019 CRFA
ASSIGNED TO LIE
Jul 12, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2019 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Feb 8, 2019 GPRN
PRIORITY ACTION E-MAILED
Feb 8, 2019 GPRA
PRIORITY ACTION WRITTEN
Feb 8, 2019 CPRA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 23, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 23, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jul 23, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jul 23, 2018 CNRT
ASSIGNED TO EXAMINER
Jul 17, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 6, 2018 NWOS
NEW APPLICATION ENTERED
Apr 3, 2018 NWAP